Brian Smith Sells 20,000 Shares of OraSure Technologies, Inc. (OSUR) Stock
OraSure Technologies, Inc. (NASDAQ:OSUR) EVP Brian Smith sold 20,000 shares of OraSure Technologies stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $17.97, for a total value of $359,400.00. Following the transaction, the executive vice president now directly owns 28,075 shares in the company, valued at $504,507.75. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website.
OraSure Technologies, Inc. (NASDAQ OSUR) opened at $17.82 on Thursday. The firm has a market capitalization of $1,083.18, a PE ratio of 34.94, a P/E/G ratio of 4.98 and a beta of 1.43. OraSure Technologies, Inc. has a 12 month low of $10.75 and a 12 month high of $23.01.
OraSure Technologies (NASDAQ:OSUR) last issued its quarterly earnings results on Wednesday, February 7th. The medical instruments supplier reported $0.12 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.11 by $0.01. The firm had revenue of $52.00 million for the quarter, compared to analysts’ expectations of $50.20 million. OraSure Technologies had a return on equity of 13.09% and a net margin of 18.52%. OraSure Technologies’s revenue was up 46.5% on a year-over-year basis. During the same quarter last year, the business posted $0.13 EPS. sell-side analysts anticipate that OraSure Technologies, Inc. will post 0.29 earnings per share for the current year.
A number of equities analysts recently weighed in on OSUR shares. Canaccord Genuity reissued a “buy” rating and issued a $24.00 price target on shares of OraSure Technologies in a research note on Friday, February 2nd. Zacks Investment Research cut OraSure Technologies from a “buy” rating to a “hold” rating in a research note on Saturday, November 4th. BidaskClub cut OraSure Technologies from a “strong-buy” rating to a “buy” rating in a research note on Thursday, February 15th. Jefferies Group cut OraSure Technologies from a “buy” rating to a “hold” rating in a research note on Thursday, November 2nd. Finally, ValuEngine cut OraSure Technologies from a “buy” rating to a “hold” rating in a research note on Thursday, November 2nd. Three equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $22.25.
ILLEGAL ACTIVITY WARNING: This report was reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this report on another site, it was stolen and republished in violation of US & international copyright and trademark legislation. The correct version of this report can be accessed at https://www.thecerbatgem.com/2018/02/22/brian-smith-sells-20000-shares-of-orasure-technologies-inc-osur-stock.html.
OraSure Technologies Company Profile
OraSure Technologies, Inc (OraSure) is involved in the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices using its technologies, as well as other diagnostic products, including immunoassays and other in vitro diagnostic tests that are used on other specimen types.
Receive News & Ratings for OraSure Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OraSure Technologies and related companies with MarketBeat.com's FREE daily email newsletter.